Clinical approach to the patient with unexpected bleeding

Area of Science:

• Hematology
• Clinical Pathology

Background:

• Unexpected bleeding can stem from disproportionate hemostatic stress or inadequately treated bleeding disorders.
• Patient history is crucial for predicting systemic hemostatic defects (congenital/acquired) versus anatomical bleeding causes.
• Bleeding characteristics (mucocutaneous, deep structures, delayed) suggest primary hemostasis, coagulation, or hyperfibrinolysis defects.

Framework:

• Clinical assessment guides the diagnostic approach, differentiating between urgent intervention and methodical investigation.
• Initial laboratory tests include hematocrit, hemoglobin, and platelet count to assess blood loss and thrombocytopenia.
• Red cell morphology, leucocyte differential, and mean platelet volume aid in identifying hypoproliferative or consumptive thrombocytopenia.

Implementation:

• Coagulation screening typically involves activated partial thromboplastin time (aPTT), prothrombin time (PT), and thrombin time (TT).
• Sufficient blood samples are essential for comprehensive testing based on initial screening results.
• Further assays may include clotting factor activity, von Willebrand factor, coagulation inhibitors, platelet function, and fibrinolytic activity markers.

Implications:

• Accurate diagnosis of bleeding disorders is critical for effective patient management.
• Tailored laboratory evaluation ensures appropriate and timely treatment.
• Understanding bleeding patterns aids in predicting underlying hemostatic or anatomical pathologies.